top of page

Project Implementation map

Figure 3.1.jpg

Research Work Packages

WP2: Development of innovative isotopic labeling strategies applicable to biotherapeutics

  • Task 2.1: Development of 2H/3H labeling strategies through hydrogen isotopic exchange

​

​

​

  • Task 2.2: Development of 13C/14C labeling strategies through carbon isotopic exchange

​

​

​

  • Task 2.3 Development of 18F labeling strategies through targeted isotopic modification

​

​

LMU.png
RFI.png
Sanofi.jpg
AZ.jpg
LMU.png
Sanofi.jpg
AZ.jpg
111447.png

WP3: Smart engineering of biotherapeutics for isotopic labeling

  • Task 3.1: Engineering of biotherapeutic proteins

​

​

​

  • Task 3.2: Engineering of oligonucleotides and analogs

​

​​

RFI.png
Sanofi.jpg
LMU.png
Sanofi.jpg
AZ.jpg
111447.png

WP4: Chemically-benign labeling of biotherapeutics/biodignostic agents and industrial applications

  • Task 4.1: Therapeutic/theranostic industrial applications of 2H/3H, 13C/14C and 18F labeled proteins

​

​

​

  • Task 4.2: Therapeutic/theranostic industrial applications of 2H/3H, 13C/14C and 18F labeled oligonucleotides

​

​​

Sanofi.jpg
Sanofi.jpg
AZ.jpg
RFI.png
LMU.png
111447.png
bottom of page